• 2004

Company Description

Mithridion develops drugs for central nervous system disorders, with special focus on schizophrenia and Alzheimer's disease.

Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer's disease and schizophrenia.